Document is current
Any future updates will be listed below
-
Authors
Petersen, Max
Dubielecka, Pat
-
Funding
Funding for this research was provided by:
NIGMS (P20GM119943)
NCI (R01CA218079)
- License Information
-
More Information
Article History
Received: 30 April 2024
Accepted: 4 July 2024
First Online: 1 October 2024
Declarations
:
: The authors declare no competing interests.
: M.P. is a paid consultant and has equity interests in XM Therapeutics. The authors declare that this conflict of interest does not influence this report.
